Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 37 | 19 | 38 | 16 | 20 |
| Gross Profit | 37 | 19 | 38 | 16 | 20 |
| Operating Expenses | 2,087 | 2,250 | 1,610 | 1,760 | 2,589 |
| Operating Income | -2,050 | -2,231 | -1,572 | -1,744 | -2,569 |
| Interest Expense | 230 | 161 | 161 | 114 | 95 |
| Other Income | -1,234 | -116 | -127 | -194 | -83 |
| Pre-tax Income | -3,514 | -2,508 | -1,860 | -2,052 | -2,747 |
| Net Income Continuous | -3,514 | -2,508 | -1,860 | -2,052 | -2,747 |
| Net Income | $-3,514 | $-2,508 | $-1,860 | $-2,052 | $-2,747 |
| EPS Basic Total Ops | -1,766.67 | -1,300.00 | -1,000.00 | -1,233.33 | -1,700.00 |
| EPS Basic Continuous Ops | -1,781.44 | -1,307.50 | -1,017.30 | -1,231.15 | -1,695.16 |
| EPS Diluted Total Ops | -1,766.67 | -1,300.00 | -1,000.00 | -1,233.33 | -1,700.00 |
| EPS Diluted Continuous Ops | -1,781.44 | -1,307.50 | -1,017.30 | -1,231.15 | -1,695.16 |
| EBITDA(a) | $-907 | $-1,909 | $-1,266 | $-1,518 | $-2,420 |